Skip to content

SOCKNLEG Compression Stocking Kit : User Friendliness

SOCKNLEG Compression Stocking Kit User Friendliness: Donning-Doffing-Edema Prevention An Open Monocentric Randomized Controlled Cross-over Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03429959
Acronym
SOCKNLEGZH
Enrollment
47
Registered
2018-02-12
Start date
2018-01-10
Completion date
2018-06-30
Last updated
2019-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Insufficiency of Leg

Brief summary

The investigators aim to evaluate the user friendliness of a newly designed leg compression stocking kit, the SOCKNLEG, compared to a standard leg compression stocking of the same compression strength, the SIGVARIS Cotton. The SOCKNLEG is not yet commercially available, whereas the SIGVARIS Cotton has been successfully commercialized for many years. After an initial screening visit, a computer generated list will allocate the participants in either the SOCKNLEG or the SIGVARIS Cotton group. All participants will try on both study stockings, in the order of their allocated group, and will rate their donning and doffing success with a questionnaire. The patients will then wear only the assigned study stocking of their allocated group, for a day and rate its comfort again at the end of the day. The donning and doffing success will also be rated by the study investigator. Leg volume measurements of the study leg will be taken at each visit to determine edema prevention.

Interventions

DEVICESOCKNLEG

Donning and doffing success compared with the two study stockings, wearing the assigned study stocking for a day, Patient Quesationnaire on donning and doffing success and wearing comfort of each study stocking

SIGVARIS Cotton

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed Consent as documented by signature * Male or postmenopausal female patient, aged over 65 years of age * Diagnosed venous insufficiency stage C3-C6 (according to CEAP (Clinical, Etiologic, Anatomic, Pathophysiologic) -classification for venous diseases)

Exclusion criteria

* Venous leg ulcer with a surface \>5cm2 * Peripheral artery disease (PAD) or media calcinosis (Ankle-Brachial-Index \<0.8 or \>1.3) * Difference in brachial blood pressure \>20mmHg in both arms * Suspected polyneuropathy with ≥4 sensible test areas, measured with the Semmes-Weinstein-Monofilament-Test * Inability to reach the forefoot with their hands * Inability to follow the procedures of the study * Bed-ridden hospitalized patients who are not able to leave the bed or sit upright for a few consecutive hours

Design outcomes

Primary

MeasureTime frame
Number of patients who completely don the two investigated leg compression devicesthrough study completion, within 7 months

Secondary

MeasureTime frameDescription
Number of patients who completely doff the two investigated leg compression devicesthrough study completion, within 7 months
Patient evaluation of user friendliness3 daysEvaluation of user friendliness using the ICC compression questionnaire
Measuring oedema prevention of the compression stockings by comparison of leg volume measurement at V4 to V3 and V4 to V2.3 daysAssessment by measuring leg volume at the morning visit 3, compared to leg volume at the evening visit 4 and by comparing the leg volumes of visit 4 (compression) to visit 2 (no compression for 1 day)
Time needed to don and doff the two investigated leg compression3 daysTime in minutes and seconds needed to don and doff each study stocking, measured by study investigator

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026